Search

everythinglearnresearchcommunity

for

Search:↓

Hair regrows faster in alopecia areata than skin re-pigments in vitiligo due to differences in stem cells and treatment effects.

γδ T cells adapt uniquely to different tissues in mice.

Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Targeting JAK-STAT1 can reduce inflammation and promote hair growth in conditions linked to EGFR deficiency.

Vaccines work well in Netherton syndrome patients, similar to healthy people.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

T cells and bacteria in the gut and skin help maintain health and protect against disease.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

γδ T cells help control tissue scarring and blood vessel growth in response to foreign objects.

Some patients with a type of skin lymphoma can experience a rare, non-scarring hair loss that looks like another hair loss condition but has distinct features.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

T-cell reconstitution after thymus transplantation can cause hair whitening and loss.

Psoriasis patients' immune response to a hair protein depends on their specific gene type.

Vesiculobullous lesions should be considered part of canine cutaneous epitheliotropic T-cell lymphoma.

Thymic transplantation normalized some T-cells but not others, maintaining immune function.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

CD4 T cells need IFN-γ to cause hair loss in alopecia areata.

Dexamethasone-primed stem cell media shows promise in treating lupus by reducing symptoms and inflammation.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

Deleting Snai2 and Snai3 causes fatal autoimmunity.

Inflammation plays a key role in activating skin stem cells for hair growth and wound healing, but more research is needed to understand how it directs cell behavior.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.